S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

RGNX REGENXBIO Inc

6.11

0.00 (0.00%)

Pre Market

Last Updated: 20:21:20

Delayed by 15 minutes

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

REGENXBIO (NASDAQ:RGNX)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more REGENXBIO Charts.

REGENXBIO (NASDAQ:RGNX)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more REGENXBIO Charts.

REGENXBIO Inc News

REGENXBIO Announces Presentations at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Monday 10 March 2025 (2 days ago) • PR Newswire (US)

Form 8-K - Current report
Wednesday 5 March 2025 (1 week ago) • Edgar (US Regulatory)

REGENXBIO Announces Closing of Strategic Partnership with Nippon Shinyaku for MPS Diseases
Tuesday 4 March 2025 (1 week ago) • PR Newswire (US)

REGENXBIO to Host Conference Call on March 13 to Discuss Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights
Thursday 27 February 2025 (2 weeks ago) • PR Newswire (US)

REGENXBIO to Participate in Upcoming Investor Conferences
Wednesday 26 February 2025 (2 weeks ago) • PR Newswire (US)

REGENXBIO Announces Presentations of RGX-121 at the 21st Annual WORLDSymposium 2025
Thursday 30 January 2025 (1 month ago) • PR Newswire (US)

Form 8-K - Current report
Tuesday 14 January 2025 (2 months ago) • Edgar (US Regulatory)

REGENXBIO and Nippon Shinyaku Announce Exclusive Partnership to Develop and Commercialize RGX-121 and RGX-111 for MPS Diseases
Tuesday 14 January 2025 (2 months ago) • PR Newswire (US)

AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program
Tuesday 14 January 2025 (2 months ago) • PR Newswire (US)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 9 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (2 months ago) • Edgar (US Regulatory)

More REGENXBIO Inc News Articles

Commonwealth Bank Of Aus...

S&P ASX 300 Metals and M...

Verizon Communications

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions